To: Mrs. Danielle McCann—Minister of Health and Social Services, Québec
"We support coverage of CGMs for certain patients with diabetes as indicated in our clinical practice guideline, “Diabetes Technology—Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring Adults”, which was released in the Journal of Clinical Endocrinology & Metabolism in 2016. The guideline provides recommendations on the use of CGMs in people with diabetes based on scientific evidence and was co-sponsored by the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology. "
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.